NovoCure
NVCR
NVCR
221 hedge funds and large institutions have $1.08B invested in NovoCure in 2026 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 76 increasing their positions, 75 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
7% less funds holding
Funds holding: 237 → 221 (-16)
13% less capital invested
Capital invested by funds: $1.24B → $1.08B (-$159M)
22% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 49
Holders
221
Holding in Top 10
1
Calls
$12.2M
Puts
$8.24M
Top Buyers
| 1 | +$35.1M | |
| 2 | +$24.5M | |
| 3 | +$12.1M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$11.5M |
| 5 |
JP Morgan Chase
New York
|
+$6.59M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$7.37M | |
| 3 | -$6.94M | |
| 4 |
Morgan Stanley
New York
|
-$6.6M |
| 5 |
Goldman Sachs
New York
|
-$5.4M |
